Ildong Holdings Co., Ltd. (KRX:000230)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,410
-700 (-6.30%)
Last updated: Mar 4, 2026, 10:49 AM KST
62.15%
Market Cap 125.46B
Revenue (ttm) 620.44B
Net Income (ttm) 67.54B
Shares Out 11.29M
EPS (ttm) 5,328.78
PE Ratio 2.17
Forward PE n/a
Dividend 100.00 (0.87%)
Ex-Dividend Date Mar 30, 2026
Volume 30,280
Average Volume 46,724
Open 10,450
Previous Close 11,110
Day's Range 10,110 - 10,780
52-Week Range 5,750 - 17,170
Beta 0.30
RSI 35.90
Earnings Date Feb 6, 2026

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Sector Healthcare
Founded 1941
Employees 72
Stock Exchange Korea Stock Exchange
Ticker Symbol 000230
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.